Brief: Belite Bio Q2 Net Income USD -28.412 Million
13/08/2026 01:00
BRIEF-Belite Bio Q2 Net Income USD -28.412 Million Aug 13 (Reuters) - Belite Bio Q2 income from operations USD -34.907 million.
- Q2 pretax profit USD -28.357 million
- Q2 operating expenses USD 34.907 million
Recent news on Belite Bio
See all newsBrief: Belite Bio Announces Uplisting To The Nasdaq Global Select Market
Brief: Belite Bio Announces Multi-Market Submission Of Marketing Authorization Applications Via The Access Consortium Pathway For Tinlarebant For The Treatment Of Stargardt Disease Type 1
Brief: Belite Bio Announces Submission Of New Drug Application To The Ministry Of Health, Labour, And Welfare In Japan Under The Sakigake Designation System For Tinlarebant For The Treatment Of Stargardt Disease Type 1
Belite Bio, Inc reports results for the quarter ended June 30 - Earnings Summary
Belite Bio Q2 net loss widens on higher expenses